Targeting PDGF-CC as a promising therapeutic strategy to inhibit cholangiocarcinoma progression
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Targeting PDGF-CC as a promising therapeutic strategy to inhibit cholangiocarcinoma progression ; volume:22 ; number:1 ; day:14 ; month:11 ; year:2024 ; pages:1-16 ; date:12.2024
Journal of translational medicine ; 22, Heft 1 (14.11.2024), 1-16, 12.2024
- Creator
-
Luo, Zhenchao
Zhou, Fangfang
Tan, Canliang
Yin, Liangchun
Bao, Man
He, Xiang
Li, Haohui
Yan, Jian
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-024-05857-6
- URN
-
urn:nbn:de:101:1-2502040951456.031129647266
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Luo, Zhenchao
- Zhou, Fangfang
- Tan, Canliang
- Yin, Liangchun
- Bao, Man
- He, Xiang
- Li, Haohui
- Yan, Jian
- SpringerLink (Online service)
Other Objects (12)
Biological responses to PDGF-AA versus PDGF-CC in renal fibroblasts
Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke
Osteoclasts control osteoblast chemotaxis via PDGF-BB/PDGF receptor beta signaling
Serum levels of PDGF-CC as a potential biomarker for the diagnosis of Kawasaki disease
Cholangiocarcinoma
Immunhistochemischer Nachweis von PDGF B, PDGF-β-Rezeptoren [PDGF-beta-Rezeptoren] und IGF-I-Rezeptoren während der Atherogenese beim Menschen
A new promising oncogenic target (p.C382R) for treatment with pemigatinib in patients with cholangiocarcinoma
Functionalized graphene oxide as a nanocarrier for multiple suppressive miRNAs to inhibit human intrahepatic cholangiocarcinoma
Blocking PDGF-CC signaling ameliorates multiple sclerosis-like neuroinflammation by inhibiting disruption of the blood–brain barrier
Targeting folliculin to selectively inhibit mTORC1: a promising strategy for treating nonalcoholic fatty liver disease
The effect of combined PDGF-B and PDGF-C deficiency on mouse development and brain vasculature
Expression, Lokalisation und funktionelle Bedeutung von PDGF und PDGF-Rezeptoren in der Hypophyse und in Hypophysentumorzellen
Biological responses to PDGF-AA versus PDGF-CC in renal fibroblasts
Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke
Osteoclasts control osteoblast chemotaxis via PDGF-BB/PDGF receptor beta signaling
Serum levels of PDGF-CC as a potential biomarker for the diagnosis of Kawasaki disease
Cholangiocarcinoma
Immunhistochemischer Nachweis von PDGF B, PDGF-β-Rezeptoren [PDGF-beta-Rezeptoren] und IGF-I-Rezeptoren während der Atherogenese beim Menschen
A new promising oncogenic target (p.C382R) for treatment with pemigatinib in patients with cholangiocarcinoma
Functionalized graphene oxide as a nanocarrier for multiple suppressive miRNAs to inhibit human intrahepatic cholangiocarcinoma
Blocking PDGF-CC signaling ameliorates multiple sclerosis-like neuroinflammation by inhibiting disruption of the blood–brain barrier
Targeting folliculin to selectively inhibit mTORC1: a promising strategy for treating nonalcoholic fatty liver disease
The effect of combined PDGF-B and PDGF-C deficiency on mouse development and brain vasculature
Expression, Lokalisation und funktionelle Bedeutung von PDGF und PDGF-Rezeptoren in der Hypophyse und in Hypophysentumorzellen
Biological responses to PDGF-AA versus PDGF-CC in renal fibroblasts
Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke
Osteoclasts control osteoblast chemotaxis via PDGF-BB/PDGF receptor beta signaling
Serum levels of PDGF-CC as a potential biomarker for the diagnosis of Kawasaki disease
Cholangiocarcinoma
Immunhistochemischer Nachweis von PDGF B, PDGF-β-Rezeptoren [PDGF-beta-Rezeptoren] und IGF-I-Rezeptoren während der Atherogenese beim Menschen
A new promising oncogenic target (p.C382R) for treatment with pemigatinib in patients with cholangiocarcinoma
Functionalized graphene oxide as a nanocarrier for multiple suppressive miRNAs to inhibit human intrahepatic cholangiocarcinoma
Blocking PDGF-CC signaling ameliorates multiple sclerosis-like neuroinflammation by inhibiting disruption of the blood–brain barrier
Targeting folliculin to selectively inhibit mTORC1: a promising strategy for treating nonalcoholic fatty liver disease
The effect of combined PDGF-B and PDGF-C deficiency on mouse development and brain vasculature